Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.56 |
| ▸ | ESR1 | P03372 | 5/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.50 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | EBP | Q15125 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6745263 | 0.99 | LTA4H (0.55) | LTA4HESR1BCHEACHEESR2 | |
| SCHEMBL6745462 | 0.94 | ESR1 (0.61) | LTA4HESR1BCHEACHEESR2 | |
| Hydrochloric Acid SCHEMBL6751621 | 0.93 | ESR1 (0.60) | LTA4HESR1BCHEACHEESR2 | |
| SCHEMBL6744378 | 0.89 | ESR1 (0.58) | LTA4HESR1ESR2 | |
| SCHEMBL6744827 | 0.89 | LTA4H (0.60) | LTA4HESR1BCHEACHEESR2 | |
| Hydrochloric Acid SCHEMBL6749894 | 0.88 | ESR1 (0.59) | LTA4HESR1ESR2 | |
| Hydrochloric Acid SCHEMBL6749948 | 0.88 | LTA4H (0.58) | LTA4HESR1BCHEACHEESR2 | |
| SCHEMBL7442980 | 0.84 | LTA4H (0.58) | LTA4HESR1ESR2PSMB1PSMB5 | |
| Hydrochloric Acid SCHEMBL6751611 | 0.82 | ESR1 (0.66) | ESR1ESR2 | |
| SCHEMBL6748810 | 0.82 | ESR1 (0.63) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6703407-B1 | TREATMENT OF MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION | ELI LILLY AND COMPANY | 2004-03-09 | — | — | US | disclosed |
| EP-0774966-B1 | BENZOFURAN COMPOUNDS, COMPOSITIONS, AND METHODS | LILLY CO ELI (US) | 2003-11-05 | — | — | EP | disclosed |
| US-6407243-B1 | POSTMEMOPAUSE DISEASES | ELI LILLY AND COMPANY | 2002-06-18 | — | — | US | disclosed |